Thrombospondin-1 Small Interfering RNA-Loaded Lipid Nanoparticles Inhibiting Intimal Hyperplasia of Electrospun Polycaprolactone Vascular Grafts
ACS Nano · 2025
DOI: 10.1021/acsnano.4c09419 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2025. Verfasst von Jiayin Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China. Hauptthemen laut MEDLINE: Polyesters, Nanoparticles, Thrombospondin 1, RNA, Small Interfering. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Zhejiang Province, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Synthetic vascular grafts are promising conduits for small caliber arteries. However, due to restenosis caused by intimal hyperplasia, they cannot keep long patency in vivo. In this work, through single cell RNA sequencing, we found that thrombospondin-1 (THBS1) was highly expressed in the regenerated smooth muscle cells (SMCs) in electrospun polycaprolactone (PCL) vascular grafts. The expression of THBS1 by injured SMCs was confirmed in a balloon-induced vascular injury model. Downregulation of Thbs1 expression maintained contractile phenotypes of SMCs and reduced neointimal hyperplasia after vascular injury via inhibition of FGFR1/EGR1 signaling by decreasing THBS1 expression. THBS1 small interfering RNA (THBS1-siRNA) was then loaded into macrophage membrane (MM) hybrid lipid nanoparticles (Lipid NP@MM), which were used to modify PCL vascular grafts via polydopamine (PDA) coatings. Lipid NP@MM not only protected THBS1-siRNA from degradation but also improved its internalization by SMCs to decrease the level of THBS1 expression. PCL vascular grafts modified with PDA coatings and Thbs1-siRNA-loaded Lipid NP@MM showed significantly reduced intimal hyperplasia. Thus, the downregulation of THBS1 expression in regenerated SMCs in vascular grafts is a promising strategy to inhibit intimal hyperplasia during vascular graft regeneration in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310016, China.
- Zhejiang Key Laboratory of Cardiovascular Intervention and Precision Medicine, Hangzhou 310016, China.
- Engineering Research Center for Cardiovascular Innovative Devices of Zhejiang Province, Hangzhou 310016, China.
ORCID-Profile: Jiayin Fu, Ning Zhang
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
- Zhejiang Province
Zitieren
APA
Fu, J., Zhang, N., Xu, C., Zhao, M., Wu, S., Xu, S., Hong, X., Wang, M., & Fu, G. (2025). Thrombospondin-1 Small Interfering RNA-Loaded Lipid Nanoparticles Inhibiting Intimal Hyperplasia of Electrospun Polycaprolactone Vascular Grafts. ACS Nano. https://doi.org/10.1021/acsnano.4c09419
Vancouver
Fu J, Zhang N, Xu C, Zhao M, Wu S, Xu S, et al. Thrombospondin-1 Small Interfering RNA-Loaded Lipid Nanoparticles Inhibiting Intimal Hyperplasia of Electrospun Polycaprolactone Vascular Grafts. ACS Nano. 2025. doi:10.1021/acsnano.4c09419
BibTeX
@article{Fu2025,
author = {Fu, Jiayin and Zhang, Ning and Xu, Changfu and Zhao, Meng and Wu, Shaofei and Xu, Shihui and Hong, Xulin and Wang, Meihui and Fu, Guosheng},
title = {Thrombospondin-1 Small Interfering RNA-Loaded Lipid Nanoparticles Inhibiting Intimal Hyperplasia of Electrospun Polycaprolactone Vascular Grafts},
journal = {ACS Nano},
year = {2025},
doi = {10.1021/acsnano.4c09419}
}
EUVIMED